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1. Introduction 
The flavivirus genus in the Flaviviridae family comprises over 70 species, most of which are 
tick- or mosquito-borne. They are single-stranded, plus-sense RNA viruses, responsible for 
significant human and animal morbidity and mortality on all inhabited continents. 
Medically important viscerotropic flaviviruses include dengue, found equatorially across 
the world, and the prototypic yellow fever virus, found in Africa and South America. 
Neurotropic members include tick-borne encephalitis virus (TBEV) in Europe, West Nile 
virus (WNV) in Africa, parts of Europe and the Indian subcontinent, as well as the USA, St 
Louis encephalitis virus in the USA, and Japanese encephalitis (JEV) and Murray Valley 
encephalitis (MVE) viruses in Australasia. Many of these have a history of emergence and 
re-emergence; indeed, following a novel outbreak in 1999 in New York (Lanciotti et al., 1999; 
CDC, 2010), WNV spread virtually throughout the Americas in less than 10 years and is the 
most common cause of meningoencephalitis in North America. WNV is now perhaps the 
most widely spread of all flaviviruses and may comprise 4 or more lineages, based on 
isolate homologies (C.G. Hayes, 2001; Bakonyi et al., 2005; Vazquez et al., 2010), with 
Lineage I and II well-defined and of obvious clinical importance in animals and humans 
(E.B. Hayes et al., 2005; Venter et al., 2009). WNV was first isolated in 1937 in the West Nile 
region of Uganda (Smithburn et al., 1940). It is a member of the Japanese encephalitis 
serogroup, together with JEV, Murray Valley and Saint Louis encephalitis viruses 
(Poidinger et al., 1996). These viruses are usually propagated in a zoonotic cycle between 
mosquitoes and amplifying hosts, particularly birds (or pigs in the case of JEV), with 
humans being incidental, since they may not develop high enough virus titres to infect 
arthropod vectors (C.G. Hayes, 2001). Rare cases of human-to-human WNV transmission 
have been documented via organ transplants and blood transfusion, as well as vertical 
transmission to the foetus in utero (Iwamoto et al., 2003; Lindsey et al., 2009). Although less 
than one percent of WNV infections develop neuroinvasive disease, in some 60% of patients 
presenting with central nervous system (CNS) symptoms denoting neuroinvasive disease, 
life-threatening encephalitis supervenes (Samuel & Diamond, 2009). The young, 
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immunocompromised and elderly are at highest risk of developing encephalitis (Weiss et 
al., 2001; Guarner et al., 2004; Lindsey et al., 2009). Climate change, geographic factors and 
international travel, as well as local factors, such as mosquito rates and land clearing (E.A. 
Gould & Higgs, 2009) are cited as influencing the spread and prevalence of arbovirus 
infections across the globe. Despite considerable effort, the only successful live attenuated 
vaccine for neurotropic flaviviruses is for JEV (X. Liu et al., 2011), although considerable 
success has been achieved with a killed vaccine for TBEV (Barrett et al., 2003; Heinz et al., 
2007). Treatment for all flavivirus encephalitides remains palliative. Indeed, one of the 
cardinal features of flavivirus infection complicating treatment approaches is 
immunopathology, evident in human cases and demonstrable in various animal models. In 
this review, we analyse the principal elements involved in the immunopathogenesis of 
flavivirus disease, with a view to novel constructive approaches to disease intervention. 
2. Local flavivirus infection - responses of infected cells 
Live WNV infection of various cell types leads to an upregulation of various cellular 
adhesion molecules, either directly or co-modulated by cytokines (Shen et al., 1995b; Shen et 
al., 1997; Arnold et al., 2004). These molecules include major histocompatibility complex 
(MHC) class I and II, intracellular adhesion molecule-1 (ICAM-1), vascular cellular adhesion 
molecule-1 (VCAM-1) and E-selectin (King & Kesson, 1988; Argall et al., 1991; Shen et al., 
1997; Verma et al., 2009). The increase in MHC-I in mouse embryonic fibroblasts is 
independent of tumour necrosis factor (TNF) (Cheng et al., 2004b), although many cell types 
produce it in response to infection. In both mouse embryonic fibroblasts and human skin 
fibroblasts it can be induced by type I interferon (IFN)-dependent and -independent 
pathways (King & Kesson, 1988; Kesson & King, 2001; Cheng et al., 2004a), with the IFN-
independent pathway relying on the activation of the transcription factor nuclear factor-κB 
(Kesson & King, 2001). This seemingly paradoxical increase in immune recognition molecule 
expression may enable evasion of early NK responses in vivo (Lobigs et al., 2003). 
3. Earliest local changes in dermis and draining lymph nodes 
Flaviviruses, transmitted by the bite of an infected mosquito, are injected with saliva during 
feeding. While several structural cell types are likely to come into contact with injected 
virus, the first leukocyte subset that virus is likely to encounter is the Langerhans cell (LC). 
LC are dendritic cells (DC) in the epidermis replenished by myeloid precursors in the bone 
marrow (BM) (Steinman, 1991; Merad et al., 2002). Following cutaneous inoculation, virus 
may infect LC, which increases cell surface expression of MHC-I, MHC-II, adhesion 
molecules, as well as costimulatory molecules, such as CD80, differentiating into a 
migratory phenotype in the process (Johnston et al., 1996). LC migrate to draining lymph 
nodes (DLN) in an accelerated manner in response to live virus, due to the induced soluble 
factor milieu (Johnston et al., 2000). In vivo experiments in mice show that the cytokine IL-1β 
is crucial for the emigration of LC from the epidermis to DLN (Byrne et al., 2001). It is 
presumed that these DC pass antigen to CD8α+ DC in the DLN, since LC alone evidently do 
not initiate antiviral immune responses (Allan et al., 2003; Kissenpfennig et al., 2005; Hildner 
et al., 2008), but direct evidence of WNV antigen transfer has yet to be shown. While 
mosquito saliva may skew adaptive responses towards a more Th2-like response profile 
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(Schneider et al., 2007; Schneider et al., 2010), it is still unclear how its early presence 
influences disease outcome, since WNV infection in the genetic absence of IFN-γ still results 
in the generation of neutralising immunity (King et al., 2003). Arrival of virus in the DLN is 
accompanied by significant induction of CCL2 expression there that recruits monocyte-
derived macrophages (MDM) from the bone marrow. The bone marrow undergoes a 
significant myeloid response to infection, releasing monocytes with a qualitatively different 
phenotype from the homeostatic state. Monocytes rapidly become TipDC (producing TNF 
and nitric oxide) in the DLN and likely contribute to the initiation of type 1 immune 
responses by inducing more IFN-γ from responding T cells than other DC subtypes in the 
DLN (Davison & King, 2011). Since flaviviruses significantly upregulate MHC expression on 
infected cells (King & Kesson, 1988; Shen et al., 1997), it is of interest how this influences the 
outcomes of innate immune interactions, such as with NK cells, and/or bears on the 
ultimate affinities of later adaptive cytotoxic T cell responses, reviewed in detail elsewhere 
(King & Kesson, 2003; Lobigs et al., 2003; King et al., 2009). 
At the same time, at the dermal site of infection, CCL2, produced by infected cells, also 
recruits considerable numbers of MDM, which surround the infected focus, becoming DC 
within 24h of arrival. While it would appear that the DLN and dermis, by both producing 
CCL2, compete for MDM from the bone marrow, it seems likely that a subtly different 
cytokine milieu at each site selects for specific MDM subsets. This is suggested by adoptive 
transfer studies of flow cytometrically-sorted BM-derived monocyte subsets during 
infection. Thus, although similar numbers of inflammatory (Ly6Chi) monocytes migrated to 
each site, 5-fold more Ly6Clo monocytes migrated to the DLN than Ly6Chi, while some 2-
fold more Ly6Chi monocytes migrated to the focus of infection in the skin than Ly6Clo 
monocytes. Perhaps consonant with these proportions, immigrant Ly6Clo monocytes in the 
DLN were 3-fold more likely to become DC, while in the dermis, immigrant Ly6Chi cells 
were 2-fold more likely to become DC. This suggests that other chemokines may 
differentially contribute to the recruitment of these cells to the relevant site, but more 
importantly, it suggests that relevant precursors to specific cells are already ordained before 
they reach their target site, rather than necessarily being randomly and non-specifically 
recruited (e.g., by CCL2) and induced to differentiate once they have arrived. Irrespective, it 
is evident that Ly6C expression on immigrating monocytes quickly changes at both sites, 
with downregulated Ly6C expression being the end point in both subsets. Thus, as shown in 
ours and other studies, Ly6Chi monocytes arriving in response to infection quickly 
downregulate expression of this molecule (Sunderkotter et al., 2004; Leon et al., 2007; Getts 
et al., 2008; Davison & King, 2011). In contrast, at both sites, within 24h, immigrating Ly6Clo 
monocytes become Ly6Chi at the site, only to downregulate expression of this molecule 
again within a further 24h, while also upregulating CD11c to become DC. Furthermore, in 
the dermis, it is exclusively these cells originally entering the dermis as Ly6Clo monocytes, 
that then migrate from the dermis to the DLN, presumably carrying viral antigen with 
them (Davison & King, 2011). Since so many Ly6Clo cells also migrate from the BM to the 
DLN to become DC, it is tempting to speculate that these cells may differentiate into the 
final migratory couriers of antigen between the subcapsular sinus of the DLN, where DC 
arrive from the dermis via the afferent lymphatics, to the CD8α+ DC in the deep 
paracortex. 
Early antiviral activity by Ly6Chi monocyte-derived TipDC in the dermis may influence the 
outcome of infection by reducing virus titres locally; indeed, antiviral activity may account 
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for the high survival rates observed in a mucosal model of flavivirus infection after 
intravaginal inoculation of a viral dose that is lethal by all other routes. In this model, large 
numbers of DC accumulate just beneath the epidermal site of infection, essentially 
separating infected epithelium from uninfected stroma below (Burke et al., 2004). 
Interestingly, CCL2 is also strongly expressed at this site (King, Unpublished observations).  
4. Entry into the CNS 
Virus undoubtedly spreads via the bloodstream at some point to further infect peripheral 
organs, including the CNS, where neurons are the main target (Xiao et al., 2001; Shrestha et 
al., 2003; Cheeran et al., 2005; Samuel & Diamond, 2009). However, the factors controlling 
these phases of virus spread are virtually unknown. The blood of acutely viraemic human 
donors shows substantial increases in IFN-γ and α as well as IFN-stimulated CXCL10 and 
CCL2. This upregulation of cytokines and chemokines occurs before IgM seroconversion 
and is therefore argued to be involved in the initial response to acute viraemia. On the other 
hand, this could be the result of chemokine gradients from the WNV-infected brain, since 
both chemokines are increased in the WNV-infected brain (Klein et al., 2005; Getts et al., 
2008). Upregulated IL-4 was also detected in the same time frame, implicating IL-4 in early 
modulation of immune responses (Tobler et al., 2008). 
How virus gains entry into the CNS is still unclear. In some models it is argued that 
breakdown of the blood-brain barrier (BBB) enables virus entry into the CNS. Toll-like 
receptors, TLR3, 7 and 8, are responsible for detecting RNA products of viral replication and 
although TLR3 and 7 are protective against WNV (Daffis et al., 2008; Town et al., 2009; 
(Daffis et al., 2008), TLR3 has also been implicated in aiding entry of WNV into the brain. 
TLR3 knockout mice have less BBB leakiness and significantly lower viral levels in the brain 
than wild type mice, with higher viral loads in the periphery, thought to be due to reduced 
production of TNF, a cytokine strongly implicated in BBB breakdown (T. Wang et al., 2004). 
Interestingly, macrophages isolated from young humans show a marked reduction in TLR3 
levels during WNV infection, while those from elderly donors do not. TLR3 levels are 
controlled by a signal transducer and activator of transcription 1 (STAT1)-mediated 
pathway, which is downregulated by WNV E-protein in cells from young, but not elderly 
donors. Cells from elderly donors produced increased levels of inflammatory cytokines, 
including TNF (Kong et al., 2008), supporting the notion that TLR3 may play a role in 
immunopathology in the elderly, ironically via an overly aggressive immune response to 
WNV. Endothelial tight junction proteins (TJP), such as ZO-1 and claudin-1, are crucial 
components of BBB integrity and this seal is maintained, inter alia, by astrocytes, non-
neuronal support cells of the CNS that are susceptible to WNV infection in vitro (Y. Liu et al., 
1989; Cheeran et al., 2005; Verma et al., 2010). WNV-infected astrocytes increase matrix 
metalloproteinase (MMP) production to degrade TJP (Verma et al., 2010). However, 
astrocyte infection in vivo has not been reported and furthermore, BBB breakdown is quite 
variable in flavivirus infection (T.H. Liu et al., 2008; Verma et al., 2010). Alternative ways in 
which virus could cross the BBB include endothelial transcytosis and/or endothelial 
infection (German et al., 2006). However, there are few if any reports of endothelial infection 
itself in vivo by flaviviruses. Moreover, in 167 mice examined at various timepoints after 
intraperitoneal infection, where significant viraemia occurs within 6 h of inoculation, we 
saw unequivocal endothelial infection only once (King, Unpublished).  
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Trojan horse transmission into the brain by infected monocytes remains a possibility. 
Macrophages are susceptible to WNV infection (Cardosa et al., 1986; Shen et al., 1995a; Rios 
et al., 2006) and could be a crucial cell type contributing to transmission of virus into the 
brain. However, this has not been shown, and in our hands, while both human and mouse 
monocytes are readily infectable in vitro, they also very effectively control flavivirus 
infection, a point further supported in vivo by the lack of infected microglia (or for that 
matter, infiltrating macrophages) in flavivirus encephalitis (Getts et al., 2007; Getts et al., 
2008). A recent study has shown that neutrophils, recruited to the intraperitoneal infection 
site in large numbers by CXCL-1 and -2 produced by WNV-infected macrophages, exhibited 
much higher viral loads than macrophages. The removal of these chemokines or depletion 
of neutrophils prior to WNV infection resulted in delayed death of animals and reduced 
viral levels, suggesting a possible role for neutrophils as reservoirs for viral replication and 
dissemination during the early stages of WNV infection (Bai et al., 2010). However, of the 
leukocytes attracted to the brain after intranasal infection, less than 3% are neutrophils 
(King, Unpublished). The intranasal route of infection enables the separation of systemic 
anti-viral responses from those mediated by the CNS. Thus, insignificant numbers are in 
and of themselves attracted to the brain during infection, making it unlikely that they are a 
primary source of virus in neuroinvasion, although they may be a source of spread to other 
organs. Notwithstanding the susceptibility of most cells to in vitro infection with 
flaviviruses, it has yet to be convincingly demonstrated that cells in the brain parenchyma 
other than neurons become infected in in vivo infection. This begs the question of how 
infected macrophages and neutrophils specifically contribute to neuronal infection. 
Furthermore, infection via a Trojan horse scenario would presumably occur only if infected 
leukocytes or monocytes were attracted by chemotactic signals originating in the 
parenchyma of the brain, whether or not the BBB was intact. This assumes a response to 
infection, either directly, e.g., via infected neurons producing CCL2 (Getts et al., 2008), or 
indirectly via other leukocytes already attracted by infection producing chemokines that in 
turn attract infected neutrophils and monocytes, i.e., once the immune response is well and 
truly under way. Increases in virus in the brain temporally consistent with this scenario 
have not to our knowledge been reported. 
In vitro cellular adhesion molecules like E-selectin, VCAM-1 and ICAM-1 are upregulated in 
WNV infection and could support the extravasation of leukocytes into the brain (Shen et al., 
1997). Expression of ICAM-1 and VCAM-1 is clearly increased on cerebrovascular 
endothelium in WNV-infected mice in vivo and this is also associated with infiltration of 
large numbers of macrophages and microglia into the brain (Figure 1). In primary human 
brain microvascular endothelial cells, an increase in VCAM-1 and E-selectin is induced 
when viral replication is at its highest (Verma et al., 2009). Together with TLR3-mediated 
BBB breakdown, upregulated adhesion molecules could facilitate the infiltration of infected 
leukocytes into the CNS. However, it is worth noting that WNV-infected IFN-γ knockout 
mice upregulate cerebrovascular endothelial ICAM-1 and VCAM-1 expression significantly, 
but have substantially fewer immigrant leukocytes than wild type mice (King, 
Unpublished). Moreover, although WNV induces BBB permeability in some models, it may 
not be the primary route of entry into the CNS. Mice and hamsters infected with WNV 
exhibited signs of BBB leakiness at the same timepoint they succumbed to virus, indicating 
that infection of the brain began prior to the BBB becoming compromised (Morrey et al., 
2006; Morrey et al., 2008) (King, Unpublished). Similarly, in TBEV infection in mice, BBB 
breakdown occurs 2-3 days after virus is detectable in the brain (Růžek et al., 2011). 
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There is however, good evidence of centripetal nerve spread from the periphery (Engle & 
Diamond, 2003; Hunsperger & Roehrig, 2006; Getts et al., 2007). In the footpad model, viral 
infection occurs in the dermal layer of the epithelium in the footpad, which is enervated by 
sensory fibres of the dorsal root ganglion (DRG) of the peripheral nervous system (PNS). In 
vitro, PNS neurons support WNV infection and in mice the DRG is highly susceptible to 
WNV infection, suggesting that it may be involved in retrograde axonal transport of virus 
from the PNS to CNS (Hunsperger & Roehrig, 2005, 2006). This is consistent with our own 
studies using intraperitoneal inoculation of WNV in mice, where WNV is seen in the 
cervical spinal cord 1-2 days before it is seen in the brain parenchyma, spreading in a caudal 
to rostral manner. In contrast, intranasal infection results in rostral to caudal spread through 
the brain, with spread to various anatomical regions via known neural connections (King, 
Unpublished). If the sciatic nerve of golden hamsters is transected above the infection site, a 
systemic infection with less severe clinical symptoms of CNS invasion occurs (Samuel et al., 
2007), denoting a contribution to spread by intact axons. Treatment of mice with 
nocodazole, a microtubule inhibitor that prevents retrograde axonal transport, prior to 
inoculation, delays virus spread to the CNS by 6 days (Hunsperger & Roehrig, 2009). 
However, taken together, it is likely that more than one pathway is involved in WNV spread 
to the CNS, with inoculation site, dose, age and genetics all influencing this. 
 
 
Fig. 1. WNV infection results in the upregulation of ICAM-1 and VCAM-1 on brain 
vasculature in WNV encephalitis. Green = macrophages and microglia (lectin staining),  
Red = ICAM-1 (top right), VCAM-1 (bottom right) Blue = DAPI.  
Left panels = mock-infected, Right panels = d7 WNV-infected 
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5. CNS infection 
In vitro, virions attaching to the plasma membrane enter cells via clathrin-mediated 
endocytosis to form endosomes. A lysosomal, pH-dependent fusion mechanism expels the 
nucleocapsid into the cytoplasm in close proximity to the ER where the virus is thought to 
replicate (Chu & Ng, 2004). All cells of the CNS are readily susceptible to WNV infection in 
vitro within 16-24 h, including neurons, Schwann cells and astrocytes, although microglia 
are more resistant (Y. Liu et al., 1989; Argall et al., 1991; Shrestha et al., 2003; Cheeran et al., 
2005). In contrast, in animal models, detectable infection is seen in the brain between d3 and 
6 post infection (p.i.), depending on the model, with virus in all cases evidently replicating 
exclusively within neurons, a behaviour distinguishing it from the encephalitic DNA viruses 
(Steele et al., 2000; Xiao et al., 2001; King et al., 2003; Shrestha et al., 2003; Getts et al., 2007; 
Brehin et al., 2008). Antibody labelling of monkey brain sections for neuron-specific endose, 
glial fibrillary acidic protein and WNV were argued to indicate WNV infection of both glia 
and neurons, but this interpretation is not well supported by the examples provided (He et 
al., 2009). In humans, viral antigen is found in neuronal cytoplasm and processes, usually at 
the centre of microglial nodules (Sampson et al., 2000; Guarner et al., 2004). 
 
 
Fig. 2. Virus titres in the WNV-infected brain. IN = intranasal, IP = intraperitoneal infection 
Following inoculation at the periphery, WNV replicates in lymphoid tissues, but once in the 
CNS, titres increase until the onset of encephalitis (Brehin et al., 2008). Plaque assays of brain 
tissue from mice intranasally infected with WNV show much higher viral titres at the time 
of death on d7 p.i. than peripherally inoculated animals (Figure 2). After footpad 
inoculation, virus RNA can be isolated from parts of the nervous system like the brainstem, 
as early as 24 h p.i., long before the peak of viraemia and symptoms are present. There are 
also indications that the virus may be cleared, only to be followed by re-emergence in that 
area (Hunsperger & Roehrig, 2006). In the murine model of WNV infection the brain 
structures most susceptible and showing the highest viral titres appear to be the cortex, 
hippocampus, brainstem and spinal cord (Xiao et al., 2001; Hunsperger & Roehrig, 2006). In 
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humans, WNV seems to affect the brainstem and anterior horn of the spinal cord (Sejvar et 
al., 2003; Guarner et al., 2004). Neuroinvasion also occurs in animals that do not succumb to 
infection (Hunsperger & Roehrig, 2006; Appler et al., 2010). Damage to neurons can result 
from either excessive virus replication or an over-exuberant immune response, or both, with 
death ensuing in either eventuality. Increases in CD45+ leukocyte numbers as well as viral 
antigen are associated with areas of neuronal injury, degeneration by apoptosis and onset of 
encephalitis, making it difficult to distinguish between viral and immune-mediated injury 
(Xiao et al., 2001; Shrestha et al., 2003; Brehin et al., 2008). In general, mice die soon after 
seizures become evident; if seizures can be suppressed, then survival may be extended 
several days and virus growth in the brain increases by a further 10-fold or more (Getts et 
al., 2007). This indicates that the neurons are capable of supporting much higher levels of 
virus replication than is usually evident at death. Microglial nodules, perivascular cuffing, 
principally comprised of infiltrating macrophages and T cells, and in advanced disease, 
neuronal loss, are prominent among the neurohistopathological and immunohistochemical 
findings (Steele et al., 2000; Guarner et al., 2004; Petzold et al., 2010). Significant leukocyte 
infiltration seems to occur around d5 p.i., irrespective of the model used, associated with full 
activation of the adaptive immune response.  
Cells of the CNS each respond differently towards infiltrating virus. In vitro one of the 
responses to viral infection of astrocytes and microglia is the production of chemoattractants 
like CCL5 and CXCL10 (Cheeran et al., 2005), which recruit T cells and possibly monocytes; 
both astrocytes and microglia can produce CXCL9, which similarly attracts T cells (Muller et 
al., 2007) (Getts, Unpublished). Infected neurons produce copious amounts of CCL2, which 
recruit macrophages and microglia from the bone marrow (Getts et al., 2008). IFN-γ plays an 
important role in the formation of the seizure cascade during the development of the CNS, 
as IFN-γ knockout mice do not develop seizures during WNV infection. Seizures cannot be 
recapitulated by IFN-γ-producing T cells infiltrating into the brain in WNV-infected IFN-γ 
knockout chimeras previously reconstituted with wild type bone marrow. The role of the 
glutamate receptor, N-methyl-D-aspartate in the development of these seizures has also 
been shown (Getts et al., 2007). While it is clear that many soluble factors are produced in 
the brain, it is not so obvious which cells produce them in vivo. Much work will be required 
to fully characterise the sequence of inductive and inhibitory interactions between local 
cells, infected cells and immigrant leukocytes. 
6. Microglial activation 
Microglial activation is clearly associated with virus infection of neurons rather than 
immune leukocyte infiltration. After intraperitoneal inoculation, WNV can be seen in the 
brain by d6 p.i., when activated microglia are first observed, one day after leukocyte 
infiltration is first evident. However, in the intranasal model, microglial activation is seen 
at d3 p.i. when virus is first observed, while leukocyte infiltration is still seen first at d5 
p.i., as in the intraperitoneal model (Getts et al., 2008) (King, Unpublished). Microglia 
form nodules around infected neurons soon after infection (King et al., 2003; Guarner et 
al., 2004; Petzold et al., 2010), presumably recruited by the soluble factor outputs from 
infected neurons, including CCL2. Consistent with this, microglia, at first dendritic, 
quickly lose these normal projections to assume a more motile amoeboid phenotype 
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(Getts et al., 2008). Interestingly, as the number of infected neurons increases, these 
nodules become less apparent, perhaps because the concentrations of these soluble factors 
reach a virtual equilibrium within the brain, thus abrogating the concentration gradients 
likely required for nodule formation (King, Unpublished). Whether the formation of 
nodules is protective or damaging to neurons is not known, but relatively few infected 
neurons at the centre of microglial nodules are TUNEL-positive in WNV encephalitis 
(Getts et al., 2007). There is a significant increase in microglial numbers in the brain 
during infection, with a decrease in resting microglial numbers. This increase is accounted 
for by bone marrow-derived monocyte immigration and is not due to in situ proliferation 
of microglia (Getts et al., 2008). Whether immigrant microglia subsequently return to a 
resting state in the brain if the host survives and/or whether these cells have a role in the 
causation of any subsequent neurological sequelae, remains to be elucidated. 
 
 
Fig. 3. Flow cytometry showing infiltration of macrophages and microglia in the WNV-
infected and mock-infected mouse brain. R1 (green profile at right) = CD45lo-int microglia 
(mock-infected), R2 (red profile at right) = CD45lo-int microglia (WNV-infected), R3 (blue 
profile at right) = CD45hi macrophages (WNV-infected) 
Usually by d6 p.i. the whole microglial population in the brain is activated and this can be 
detected as an increase in CD45 expression by flow cytometry (Figure 3) and by their 
amoeboid morphology using lectin immunohistochemistry (Brehin et al., 2008; Getts et al., 
2008). Similar to infiltrating macrophages, activated microglia in the WNV-infected brain 
also express higher levels of Ly6C, compared to mock-infected mice. In Rhesus monkeys 
infected intracerebrally with three antigenically divergent flaviviruses, activated microglia 
are identified by their enlarged morphology, short thicker processes and CD68 expression. 
In this model, microglia are found next to dying neurons and neuronal debris where they 
perform a phagocytic function (Maximova et al., 2009). They also secrete various 
proinflammatory mediators and cytokines as part of the response to local and systemic 
infection. The increased microglial production of leukocyte-recruiting chemokines, CXCL10 
and CCL2, is triggered by the activation of the p53-mitogen-activated protein kinase and 
extracellular signal-regulated kinase intracellular signaling pathways by WNV infection 
(Cheeran et al., 2005). Neutralisation of CCL2 by antibody on d6 p.i., results in prolonged 
survival, strongly implicating microglia as contributors to fatal neuropathology (Getts et al., 
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2008). In Japanese encephalitis, bystander damage caused by activated microglia is a major 
contributor to the severity of the disease. Microglial activation is associated with elevation of 
proinflammatory mediators like TNF, IL-1β, IL-6, (inducible) nitric oxide synthase-2 (NOS2) 
and cyclooxygenase-2 (Cox-2), all of which have the potential to be neurotoxic (Ghoshal et 
al., 2007; Chen et al., 2010). Nitric oxide (NO), formed from the catalysis of arginine by 
sustained high levels of induced NOS2, can cause significant oxidative damage to neurons, 
while the production of Cox-2 results in reactive oxygen species as a byproduct that is also 
capable of inflicting irreversible damage on neurons (Ghoshal et al., 2007). TNF-induced 
endothelial expression of NOS2 and the formation of reactive nitrogen- and oxygen species 
is also implicated in the apoptosis of cells and development of hemorrhage in the murine 
model of dengue virus infection (Yen et al., 2008). 
7. Macrophage infiltration 
In mice infected with WNV by intranasal inoculation, virus is detectable only in the brain, 
making this model ideal to study brain responses to neuronal infection. In this model, the 
predominant leukocyte subtype immigrating into the brain in flavivirus encephalitis is the 
MDM (Figure 4, 5). By d7 p.i. large numbers of infiltrating macrophages can be seen 
surrounding infected neurons in the brains of WNV-infected mice. Neutralisation of CCL2 
reduces macrophage immigration into the brain, indicating that CCL2, produced by infected 
neurons, is a major driver of MDM immigration into the CNS (Getts et al., 2008; Lim et al., 
2011), however, this may later be supplemented with IL-23, which may intensify 
macrophage infiltration, or result in the recruitment of different functional macrophage 
subsets (Town et al., 2009). IL-23 is argued to originate from microglia, but this has not been 
shown. Some 35-50% of infiltrating leukocytes in the brain are Ly6Chi macrophages, with 
NK cells and Ly6C+ immigrant microglia in each case making up approximately half these 
numbers (Figure 5).  
 
 
Fig. 4. Immunohistochemistry showing myeloid lineage cells infiltrating the WNV-infected 
brain. Green = macrophages and microglia (lectin staining); Red = anti-NS-1 (WNV-infected 
neurons); Blue = DAPI. Left = Mock-infected, Right = d7 p.i. WNV-infected 
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Once in the brain, both MDM and activated microglia can process antigen and reactivate 
WNV-specific memory T cells (Ford et al., 1996; Olson & Miller, 2004), but cannot initiate 
responses in naïve T cells (Getts, Unpublished). Both cell types produce significant amounts 
of NO, presumably via NOS2 induced by IFN-γ from infiltrating T cells (Schoneboom et al., 
2000; Jana et al., 2001) (Figure 6). Pharmacological inhibition of NO at specific time points in 
an MVE model results in extended survival (Andrews et al., 1999). This is different from 
models in which NO is abrogated throughout infection, where survival is reduced (Fenyk-
Melody et al., 1998; King et al., 2007). This highlights a crucial point about models used to 
determine susceptibility to lethal flavivirus infection. While the absence or presence of a 
particular gene may dictate susceptibility, the involvement of this gene in the disease 
process may vary significantly during the course of infection. It may be critical for virus 
control at one point, but be responsible for immunopathological damage at another. This is 
further emphasised by the fact that depletion of the macrophage population throughout the 
disease course results in accelerated death (Ben-Nathan et al., 1996), while temporally 
targeted inhibition of macrophage immigration into the brain in WNV encephalitis results in 
long term survival and immunity (Getts et al., 2008). 
 
 
Fig. 5. Leukocyte subsets in the WNV-infected brain on d7 p.i. RM= resident microglia,  
IM= immigrant microglia 
Peripheral production of NO is also involved in DC-programmed T cell responses. Bone 
marrow-derived DC from NOS2 knockout mice elicited a much stronger Th1 immune 
response with increased chemokine expression. Interestingly, lack of NO-mediated 
modulation resulted in expansion of a Ly6Chi type inflammatory DC subset, implicating NO 
as a potential negative regulator of immune-mediated pathology (Giordano et al., 2010). On 
the other hand, in influenza infection, increased Th1 responses in the absence of NOS2 may 
result in higher antiviral antibody titres and more effective virus clearance with less 
immunopathology (Jayasekera et al., 2006). As with WNV encephalitis, neuroinflammation 
plays a significant role in the severity of experimental autoimmune encephalomyelitis 
(EAE). NOS2 knockout mice are much more susceptible to EAE than wild type mice (Fenyk-
d7 p.i. WNV-infected 
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Melody et al., 1998). This raises the question of the role of Ly6Chi inflammatory cells in the 
severity of neuropathology in WNV infection (Giordano et al., 2010). 
 
 
Fig. 6. Macrophages and microglia produce NO in response to WNV infection. Green = 
macrophages and microglia (lectin staining); Red = iNOS/NOS2; Blue = DAPI. Left = Mock 
infected, Right = d7 WNV 
Mice and human peripheral blood monocytes are divided into circulating and inflammatory 
subsets. As mentioned above, inflammatory monocytes are recruited to inflamed tissue by 
chemokines like CCL2, while circulating monocytes may replace resident macrophages in 
the steady state. In the murine model, circulating monocytes have Gr1-(Ly6Clo)/CX3CR1+ 
phenotype; inflammatory monocytes have a Gr1hi(Ly6Chi)/CCR2+ phenotype (Geissmann et 
al., 2003; Tacke & Randolph, 2006). As mentioned, Ly6Chi monocytes can differentiate into 
DC in the spleen and lung as well as into LC and macrophages under inflammatory 
conditions, where they are capable of stimulating naïve T-cells (Geissmann et al., 2003; Leon 
et al., 2004; Ginhoux et al., 2006; Landsman et al., 2007). During WNV infection there is a 
substantial increase in CD45int/CD11b+/CD11c- activated microglia in the brain. Depletion 
of blood monocytes reduces numbers of activated microglia in the CNS and adoptive 
transfer of Ly6Chi inflammatory monocytes from the bone marrow confirms that activated 
microglia in the CNS are derived from inflammatory monocytes in WNV infection (Getts et 
al., 2008). 
CCR2 and its ligand, CCL2, are important in the emigration of inflammatory monocytes 
from the bone marrow and migration to inflamed sites, including the CNS (Serbina & 
Pamer, 2006; Tsou et al., 2007; Getts et al., 2008; Lim et al., 2011). Immunohistochemical 
staining shows CCL2 expression by WNV-infected neurons, often with macrophages and 
microglia in close attendance (Figure 7). Recent findings however, indicate that CCR2 does 
not control the accumulation of Ly6Chi monocytes from blood to CNS directly, but rather by 
regulating the levels of monocytes in the blood (Lim et al., 2011). Interestingly the 
neutralisation of CCL2 leads to increased survival rates in WNV-infected mice, indicating 
the possible role that inflammatory cells play in the immunopathology of WNV encephalitis 
(Getts et al., 2008). CCR2 and CCR4 also seem to be involved in the pathogenesis of dengue 
virus disease. Dengue-infected CCR2 and CCR4 knockout mice show increased survival 
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rates and have decreased levels of systemic cytokines like IL-6 and IFN-γ, as well as lower 
numbers of activated NKT, CD4+, CD8+ T cells and macrophages in the spleen compared to 
wild type mice. Although the viral load in the CCR4 knockout and wild type mice was 
similar, it was suggested that the reduced mortality rates in these mice is due to reduced 
damage to organs and tissues associated with the abrogated inflammatory response 
(Guabiraba et al., 2010).  
 
 
Fig. 7. Infected neurons produce CCL2 which recruits monocytes to the brain.  
Green = macrophages and microglia (lectin staining); Red = NS-1 (actively infected 
neurons); Blue = CCL2. Left = Mock-infected, Right = d7 p.i. WNV-infected 
8. Infiltration of other leukocyte subtypes 
While up to 50% of leukocytes infiltrating into the CNS following infection are MDM, 
significant numbers of CD4+, CD8+ T cells (10-15%) and NK cells (10-20%) also immigrate 
into the brain, although there are relative few neutrophils (1-3%) (Figure 5, 8). T cells are 
recruited by increased astrocyte and microglial CXCL10 and CXCL9 expression, as well as 
CCL5 (Glass et al., 2005).  
As for mice, T cell effector subsets migrate into the perivascular space and brain 
parenchyma during flavivirus infection of monkeys. T cells are seen spread evenly 
throughout the parenchyma and perivascular space, whereas labelling for CD4+ and CD8+ 
subsets shows a more compartmentalised distribution, with CD4+ cells located mainly in the 
perivascular space. Either the CD4+ or CD8+ T cell subset may be the dominant lymphocyte 
present in CNS in infection (Kelley et al., 2003; Maximova et al., 2009). Whether they 
contribute to immunopathology or not, T cells are clearly crucial to virus clearance; mice 
deficient in this subpopulation exhibit higher mortality rates (Y. Wang et al., 2003; Y. Wang 
et al., 2006; Brien et al., 2008). Further highlighting these points, despite significantly lower 
myeloid cell infiltration in WNV infection in RAG knockout mice and prolonged survival, 
these animals die with high titres of virus in the CNS (King, Unpublished). In contrast to 
WNV, in TBEV infection in mice, immunopathology is evidently mediated by CD8+ T-
cells, although these cells are not responsible for BBB breakdown (Růžek et al., 2011). 
CD4+ T cells evidently play a protective role in TBEV, possibly via secretion of IFN-γ and 
www.intechopen.com
  
Flavivirus Encephalitis 
 
38
other pro-inflammatory cytokines and/or stimulation of ‘macrophage-like’ cells (Růžek et 
al., 2009). 
The chemokine receptor CXCR3 is a key regulator of T-cell recruitment and thus plays a 
pivotal role in the pathogenesis of many diseases (Muller et al., 2007). During WNV 
encephalitis in mice the chemokine receptor CXCR3 enables recruitment of antiviral CD8+ T 
cells to the CNS in a region-specific manner. Loss of this receptor leads to increased 
mortality rates in these animals (B. Zhang et al., 2008). TNF is also essential in the 
recruitment of antiviral CD8+ T cells to the CNS in WNV infection (Shrestha et al., 2008).  
 
 
Fig. 8. Flow cytometry showing regional analysis of infiltrating leukocytes in murine brain. 
R1 denotes CD45hi, CD11blo lymphocytes, which can be further divided into T cells and NK 
cells; R2 denotes CD45hi, CD11bhi neutrophils, which are Ly6G+, Ly6C+ 
Although B cells are also observed in the brain in some studies (Brehin et al., 2008), CD20+ B 
cells are predominantly found in the perivascular space surrounding neurons. Proportions 
of B and T cells in the brain vary depending on the infecting flavivirus (Maximova et al., 
2009). By flow cytometry, we find few B cells in the brain parenchyma and while the BBB is 
intact it seems unlikely that antibodies have a significant effect against WNV within the 
brain, although antibody is clearly important systemically in protection against WNV 
(Diamond et al., 2003). NK cells, while present in significant numbers in the brain 
parenchyma, have not been studied in any detail. Indeed, to date they have been regarded 
as redundant in flavivirus infection, since upregulated MHC expression on infected cells 
reduces NK cell recognition. However, in vitro, under artificially-stimulated conditions, NK 
cells are cytotoxic for WNV-infected cells (M. Zhang et al., 2010).  
The lack of neutrophil infiltration is perhaps not surprising as there is little or no CXCL1 
expression in the brain during infection. However, in MVE, infiltration of NO-producing 
neutrophils, attracted by TNF and N51/KC, are a significant part of the inflammatory 
leukocyte infiltration and contribute to the severity of disease. Neutrophil depletion and 
inhibition of NOS prolongs survival of infected animals and reduces the severity of 
pathology in the CNS (Andrews et al., 1999). Since the neutrophil-depleting antibody used 
also depletes monocytes, however, it is not clear to what extent immigrating macrophages 
may have contributed to lethal pathology. Nevertheless, this again highlights the point  
that temporally selective depletion may reduce pathology, while genetic deletion may 
exacerbate it. 
www.intechopen.com
 The Immunopathogenesis of Neurotropic Flavivirus Infection 
 
39 
9. Immunomodulating therapies 
Despite the large amount of research in the field, there is currently no approved antiviral 
therapy against WNV in humans and treatment remains symptomatic. Currently, the only 
live flavivirus vaccines with a relatively good record of safety are against yellow fever 
(Monath, 2010) and JEV (X. Liu et al., 2011) and the only commercially available live 
vaccines against WNV are for horses. Two highly purified formalin-inactivated whole 
virus vaccines against TBEV have been used in Europe since 1976 (FSME Immun, Baxter) 
and 1999 (Encepur, Novartis) and an efficacy of 99% has been reported in Austria, with no 
difference between age groups, and no major safety issues reported (Barrett et al., 2003; 
Heinz et al., 2007). Another avenue that is currently being investigated is antivector 
vaccines that target mosquitoes or ticks directly (Kortekaas et al., 2010). Recently, stable 
infection with the bacterium, Wolbachia, has been achieved, with significant potential for 
limiting the transmission of dengue (McMeniman et al., 2009; Bian et al., 2010). Antivirals 
like Ribavirin can successfully act against WNV in vitro (Jordan et al., 2000; Anderson & 
Rahal, 2002), but have no notable antiviral effect when used to treat infected humans 
(Chowers et al., 2001). Although initial studies with antiviral medication appeared 
promising, increased mortality rates led to several candidates being disqualified. This and 
the fact that a significant amount of neuropathology is induced by the immune system 
itself has led to more research being conducted into modulation of the immune system. 
Indeed, general immunomodulators that inhibit inflammatory mediator synthesis and can 
cross the BBB are potential candidates. Patients infected with TBEV receiving the anti-
inflammatory antibiotic, tetracycline, had reduced levels of IL-6, IL-1β, TNF, quicker 
improvement of symptoms and faster clinical recovery than untreated patients 
(Atrasheuskaya et al., 2003). 
Because interferons play such a prominent role in mitigating viral infection and modulating 
the adaptive immune system, they have been prime candidates for immunomodulating 
therapies (Samuel & Diamond, 2005; Jiang et al., 2010). IFN-α2b has protective and 
therapeutic properties in Vero cells (Anderson & Rahal, 2002). IFN-γ and β play a role in 
inhibiting viral spread and replication in the periphery as well as the CNS and are also 
argued to reduce WNV-induced neuronal death (Samuel & Diamond, 2005). RNA for 
interferon-stimulated genes (ISG) and their protein expression are upregulated during viral 
infections (Wacher et al., 2007). Five of the IFN-α-induced ISG, namely Viperin, ISG20, 
protein kinase R (PKR) and IFN-induced transmembrane proteins 2 and 3 (IFITM2, IFITM3) 
have been shown to disrupt multiple steps in the dengue and WNV life cycle. IFITM2 and 3 
in particular serve to inhibit viral entry into host cells (Jiang et al., 2010). The matrix 
metalloproteinase (MMP) inhibitor, GM6001 has been shown to reverse the damage to BBB 
integrity induced by MMPs with WNV infection (Verma et al., 2010). Cytotoxic T cells can 
eradicate WNV by lysing infected cells and this could potentially be used in developing 
treatment against WNV. The vaccination of individuals with a chimeric WNV/yellow 
fever vaccine, coding a WNV envelope antigen, results in the production of CD8+ T cells 
that persist for up to a year with similar qualities to memory T cells (Smith et al., 2010). 
Cytotoxic T lymphocytes generated against WNV-specific epitopes are able to eradicate 
infected cells in vitro as well as increase survival rates when transferred into mice. This 
approach may thus result in a more targeted immune response and optimised eradication 
of virus (Purtha et al., 2007).  
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Neutralising antibodies have also been successful in treating and preventing early infection 
in animal models and humanised antibodies could provide the basis for treatment after 
known exposure to infection (Throsby et al., 2006; Vogt et al., 2009). The use of certain 
human single chain variable fragments fused with an IgG1 Fc region is able to confer some 
protection against lethal WNV in mice. The addition of Fc region to this protein is critical for 
the effectiveness of its neutralising function and suggests whole monoclonal antibodies 
(mAbs) may more effectively neutralise WNV (L.H. Gould et al., 2005). Further supporting 
this, the neutralising potential of mAb E16 is less effective in mice lacking the Fc receptor 
(Oliphant et al., 2005). It is tempting to speculate also, that NK cell-mediated antibody-
dependent cell-mediated cytotoxicity may contribute to viral clearance in the periphery. 
Of the myriad antibodies induced by WNV infection only a few neutralise WNV and have a 
possible therapeutic role. Neutralising antibodies are mainly directed against domain III of 
the WNV envelope-protein where they prevent the conformational change in the virus 
required to fuse to cellular membranes, consequently inhibiting it from entering the cell 
(Oliphant et al., 2005; Throsby et al., 2006; Morrey et al., 2007; S. Zhang et al., 2009). 
Polyclonal antibodies promote survival in B- and T cell-deficient mice, indicating their 
therapeutic potential (Engle & Diamond, 2003). The axonal spread of virus can also be 
blocked by neutralising antibodies in vitro and in vivo (Samuel et al., 2007). Two neutralising 
human monoclonal antibodies with therapeutic potential are CR4348 and CR4354, both 
capable of inhibiting WNV in vitro and in vivo. They bind to epitopes on the E-protein of the 
virus and neutralise the virus at the postattachment step, it is thought by preventing fusion 
of the virus to the endosomal membrane. Prophylactic treatment with these antibodies 
protects mice against lethal WNV infection (Vogt et al., 2009). On the other hand, humanised 
mAb E16 is able to increase survival of both mice and hamsters, even when administered 
after the CNS is infected (Oliphant et al., 2005; Morrey et al., 2007). The treatment of 
hamsters 5 days after WNV inoculation with this E16 antibody also results in decreased 
viral burden in the CNS and increased survival (Morrey et al., 2006). The affinity of 
neutralising antibodies has also been associated with neutralising efficacy. Affinity alone, 
however, does not ensure the efficacy of inhibiting WNV activity, as some non-neutralising 
antibodies bind with high affinity to their epitopes. Thus, not surprisingly, both the specific 
epitope and binding affinity play a role (Sanchez et al., 2005).  
Other factors limiting antibody-mediated treatment include the poor movement of 
antibodies across an intact BBB to enable them to act on virus-infected neurons (Cheeran et 
al., 2005; Morrey et al., 2007) and the possibility that mutant virus strains might arise 
through antibody treatment. For example, mutations of the E16 epitope of the virus can 
abrogate the neutralising activity of monoclonal antibodies (Li et al., 2005; Sanchez et al., 
2005). Thus, although resistant strains to specific mAbs are currently rare, they need to be 
considered in the design of antibody therapy (S. Zhang et al., 2009). Time of therapeutic 
administration and viable administration routes for human patients are also important 
considerations because of the possibility that antibodies could further exacerbate disease via 
antibody-dependent enhancement of infection. This classically occurs in a second dengue 
infection. Here, virus-specific antibodies from a first dengue infection with a low affinity for 
the second strain of dengue do not neutralise, but complex with virus. This enables virus to 
gain access to monocytes, macrophages and mature DC via Fcγ receptors typically borne by 
the myeloid lineage, resulting in increased viral loads in individual cells, as well as 
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increasing numbers of productively-infected cells (Halstead & O’Rourke, 1977; Boonnak et 
al., 2011). 
This currently leaves cell subset targeting as an immunomodulating therapy, but issues 
about which subset(s) to target, how to target them effectively and when to target them 
during disease remain to be resolved. However, the temporal targeting of 
immunopathological subsets and/or the enhancement of potentially anti-inflammatory 
subsets in viral encephalitis, with the idea of enabling successful virus clearance by the 
remaining elements of the adaptive immune response, remain a legitimate goal, since, 
unlike the long-term requirement for subset blockers in e.g., multiple sclerosis, which may 
be associated with progressive multifocal leukoencephalopathy, short-term use is much less 
likely to have permanent sequelae. 
10. Conclusion 
Research on WNV and flaviviruses in general has increased dramatically in the last 10 years, 
since the advent of WNV in New York in August 1999. It has become clear that different 
flaviviruses have different interactions with the immune system and what may be 
pathogenic in one infection may prolong survival in another. This is undoubtedly further 
complicated by the variability of human (and mouse) genetics, as well as the variety of 
disease models. While it may eventually be possible to personalise treatments ranging from 
cancer to infectious disease, at this stage we do not know enough about the pathogenesis of 
these infections to inform the kind of generic approach required to intervene to prevent 
lethal disease in a meaningful number of patients successfully. While it seems likely that an 
effective vaccine will eventually be available, many issues have to be addressed before 
general immunisation is a viable proposition. Notwithstanding the success of this 
endeavour, there will always be individuals in which it will be necessary to intervene 
clinically, due to poor vaccine compliance, failure of vaccination, as well as other 
uncontrollable factors. Unlike species-specific viruses like smallpox, the pleotropic nature of 
flaviviruses, their carriage by migratory wild birds capable of amplifying them, the 
difficulty of eradicating their arthropod vectors, in addition to other factors, many of our 
own making, that continue to extend vector habitats, will make them virtually impossible to 
eradicate by vaccination. 
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